- Termination of Registration of a Class of Security under Section 12(g) (15-12G)
15 Juillet 2009 - 9:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File No. 000-31129
HOLMES BIOPHARMA, INC
.
(Exact name of registrant as specified in its charter)
375 N. Stephanie Street, Suite 1411, Henderson, Nevada 89014-8909
Telephone 702-866-2500
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
COMMON STOCK
(Title of each class of securities covered by this Form)
NONE
(Titles of all other securities for which a duty to file reports under section 13(a) and 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
Rule 12g-4(a)(1)
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(1)(ii)
Rule 15d-6
|
[X]
[ ]
[ ]
[ ]
[ ]
|
Approximate number of holders of record as of the certification or notice date:
150
Pursuant to the requirements of the Securities Exchange Act of 1934 Holmes Biopharma, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
Date: July 15, 2009
|
By:
/s/ Thomas Wikstrom
Thomas Wikstrom, President
|
Swiftsure (CE) (USOTC:HLMB)
Graphique Historique de l'Action
De Mai 2024 à Mai 2024
Swiftsure (CE) (USOTC:HLMB)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
Real-Time news about Swiftsure International Inc (CE) (OTCMarkets): 0 recent articles
Plus d'articles sur Holmes Biopharma (OTC)